TNFRSF11A and cancer: More recently, RANK/RANKL signaling was also found to be an essential component in carcinogenesis, specifically in the maintenance of self-renewal of cancer stem cells and up-regulation of anti-apoptotic pathways, making the RANK/RANKL axis an attractive therapeutic target [7].